Founded in 1993, BB Biotech is one of the world’s leading biotech investors. The Swiss company primarily invests in biotechnological firms that operate in various sectors, including oncology, cardiovascular, autoimmune, metabolic and infectious diseases. BB Biotech’s portfolio consists of 20-35 companies, such as Celgene, Incyte, Ionis Pharmaceuticals, Gilead, Vertex Pharmaceuticals, Radius Health, Neurocrine Biosciences, Alexion Pharmaceuticals, Agios Pharmaceuticals, Novo Nordisk, etc. Headquartered in Kusnacht, Switzerland, the BB Biotech share price (BION) is set and traded on the SIX Swiss Exchange, Frankfurt Stock Exchange and Borsa Italiana. GBP/USD in focus ahead of FED and BOE meetings Both the Federal Reserve and Bank of England will deliver their updated monetary policies this week, with GBP/USD likely to experience increased momentum.
20 hours ago
The markets expect FOMC to cut but outlook in 2025 is less certainMarkets expect a 25bp rate cut at the FOMC meeting on December 18, 2024, amid strong U.S. economic data. However, the outlook for 2025 remains uncertain as inflation and growth trends evolve.
12:20, 17 December 2024
Pi Network coin price prediction: Third party price targetDiscover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
12:20, 13 December 2024
Projected US interest rates in 5 years: Third party round upAs the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
08:24, 13 December 2024